← Back to All Filings

INSMED Director Utpal Koppikar Receives Annual Equity Grant

Low SignificanceOctober 20, 2026 at 9:38:01 PM UTC

INSMED Inc

$INSM4CIK: 0001104506

Subscribe to track INSM

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

=== INSMED INC (INSM) FORM 4 FILING ===
Insider: Koppikar Utpal
Role: Director
Transaction Date: 2026-10-19
Transaction Type: Grant/Award (Code A)
Shares Acquired: 6,139
Price Per Share: $0.00
Total Value: $0.00
Post-Transaction Direct Holdings: 6,139 shares
Significance: Low (Routine Director Compensation/RSU Award)

Comprehensive Analysis

Executive Summary

On October 20, 2026, INSMED Inc ($INSM) filed a Form 4 reporting an equity award to Director Utpal Koppikar. On October 19, 2026, Koppikar acquired 6,139 Restricted Stock Units (RSUs) for $0.00 consideration under the company's Amended and Restated 2019 Incentive Plan.

Key Transaction Details

  • Reporting Person: Utpal Koppikar, Director
  • Security: Common Stock (RSUs)
  • Transaction Code: A (Grant/Award)
  • Number of Shares: 6,139
  • Price Per Share: $0.00
  • Total Transaction Value: $0.00
  • Vesting Terms: The RSUs vest in three equal annual installments on each anniversary of the grant date, subject to continuous service on the Board.
  • Post-Transaction Holdings: 6,139 shares owned directly.

Market and Sentiment Impact

This transaction represents routine board equity compensation rather than open-market buying or selling. Because this is a scheduled equity award under the company's incentive plan, the trading significance is categorized as Low, indicating no direct directional signal on company performance.

Topics:#INSM#Insmed#InsiderTrading#Form4#Biotech#SEC

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.